Table: Aska Pharmaceutical Holdings -2021/22 group results

ASKA Pharmaceutical Holdings

12/05/2022 07:00

May 12 (Reuters)- 
          Aska Pharmaceutical Holdings Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           56.61                          57.50                 
                                              (+1.6 pct)               
  Operating        4.80                           4.20                 
                                              (-12.4 pct)              
  Recurring        4.88                           4.30                 
                                              (-11.9 pct)              
  Net
  Net              4.29                           3.30                 
                                              (-23.1 pct)              
  EPS          151.22 yen                     116.32 yen               
  Ann Div       15.00 yen                      16.00 yen               
  -Q2 Div       7.00 yen                       8.00 yen                
  -Q4 Div       8.00 yen                       8.00 yen                
  
  NOTE - Aska Pharmaceutical Holdings Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4886.T